# EDGAR Filing Document

**Accession Number:** 0000021076
**File Stem:** 0001206774-26-000296
**Filing Date:** 2026-5
**Character Count:** 9502
**Document Hash:** a5cf90c733a4c84c2f5f65583e9bbaa4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001206774-26-000296.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001206774-26-000296

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260526

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260528

**DATE AS OF CHANGE**: 20260528

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLOROX CO /DE/
- **CENTRAL INDEX KEY:** 0000021076
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 310595760
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07151
- **FILM NUMBER:** 261035578

**BUSINESS ADDRESS:**
- **STREET 1:** THE CLOROX COMPANY
- **STREET 2:** 1221 BROADWAY
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1888
- **BUSINESS PHONE:** 5102717000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 24305
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1305

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 26, 2026

![](clx4644261-8kx1x1x1.jpg)

THE CLOROX COMPANY

(Exact name of registrant as specified in its charter)

Delaware 1-07151 31-0595760 <br> (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

**1221 Broadway, Oakland, California** **94612-1888** (Address of principal executive offices) (Zip code)

**(510) 271-7000**

(Registrant's telephone number, including area code)

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock - $1.00 par value | CLX | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◻

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

(b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the "Board") and Chief Executive Officer ("CEO") of The Clorox Company (the "Company"), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons. Ms. Rendle will remain as Chair and CEO while the search is conducted and until the new CEO is appointed. Ms. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition.

**Item 7.01 Regulation FD Disclosure.**

On May 28, 2026, the Company announced that the Board will initiate a comprehensive CEO search process, with Ms. Rendle to step down following the appointment of the new CEO. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits** 

**(d) Exhibits**

See the Exhibit Index below.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| [99.1](clx4644261-ex991.htm) | [Press Release dated May 28, 2026 of The Clorox Company](clx4644261-ex991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | THE CLOROX COMPANY | THE CLOROX COMPANY |
| Date: May 28, 2026 | By: | /s/ Angela Hilt |
|  |  | Angela Hilt |
|  |  | Executive Vice President - Chief Legal and |
|  |  | External Affairs Officer & Corporate Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| **PRESS RELEASE** | ![](clx4644261-ex991x1x1.jpg) |

---

Clorox Board of Directors to Initiate Comprehensive CEO Search Process

*Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO* 

**OAKLAND, Calif., May 28, 2026** — The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support of a leading executive search firm.

"Linda has been an exceptional CEO for Clorox, steering the company through a period of significant transformation and volatility," said Matthew J. Shattock, lead independent director of The Clorox Company Board of Directors. "She has helped make the company stronger, more agile and better positioned for the future. Linda has modernized our digital and operational foundation, sharpened the portfolio toward faster-growing health and hygiene categories, and accelerated innovation while continuing to invest in our brands, people and growth. While we are saddened by her decision, we are grateful that she will remain in place during the search and as an advisor for a period after the new CEO is appointed. We fully respect and support her personal decision and are confident that the process we are putting in place will result in a strong leader who is well positioned to lead Clorox into its next chapter of growth and value creation."

"Serving as CEO of Clorox for the past six years—and being part of this special company for more than two decades—has truly been the privilege of my career," said Rendle. "This was an incredibly difficult and deeply personal decision but after thoughtful reflection, I believe now is the right time to begin working toward a leadership transition so I can focus more fully on my health and family once a successor is appointed.

I remain fully committed to leading Clorox in the coming months through this transition and ensuring a smooth handoff to the company's next leader. I'm proud of what our team has accomplished during one of the most consequential periods in the company's history. Our experienced management team remains fully focused on strengthening execution, advancing innovation and delivering superior customer value as we continue to restore profitable growth and market share. While the operating environment remains challenging, I'm confident the actions we are executing today are positioning Clorox for long-term success."

Rendle posted a personal message regarding her decision on the company's website.

Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference on Wednesday, June 3, in Paris at 12pm CEST. The webcast can be accessed here.

**About The Clorox Company**

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita<sup>®</sup>, Burt's Bees<sup>®</sup>, Clorox<sup>®</sup>, Fresh Step<sup>®</sup>, Glad<sup>®</sup>, Hidden Valley<sup>®</sup>, Kingsford<sup>®</sup>, Liquid-Plumr<sup>®</sup>, Pine-Sol<sup>®</sup> and Purell<sup>®</sup> as well as international brands such as Chux<sup>®</sup>, Clorinda<sup>®</sup> and Poett<sup>®</sup>. Visit thecloroxcompany.com to learn more.

**<u>Media Contact:</u>**

corporate.communications@clorox.com

**<u>Investor Relations Contact:</u>**

investorrelations@clorox.com

CLX-F

###